Sign inJoin waitlistJoin the waitlist

Maged Guirguis

Chief System Lead, Interventional Pain Management - OCF · Louisiana State University School of Medicine

Credentials: · · · · ·

History

Sr. Education Program Manager · Ochsner Clinic Foundation
Present
Interventional Pain Management - OCF Division · Louisiana State University School of Medicine
Present
Ochsner Clinic Foundation
Present

Pain Medicine
Cleveland Clinic Foundation
2013–2014
jolytaz hospital
2010–2013
El Mahabba Hospital
2007–2010
Anesthesiology
Cleveland Clinic Foundation
2004–2007
Ain Shams University hospitals
2003–2004
AIN SHAMS UNIV, FAC OF MED, ABBASIA, CAIRO, EGYPT
1999–2003

Research

Retrospective review of 707 cases of spinal cord stimulation: indications and complications
Pain Practice · 2011 · 252 citations
Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial
JAMA Neurology · 2021 · 225 citations
Cooled Radiofrequency Ablation Compared with a Single Injection of Hyaluronic Acid for Chronic Knee Pain: A Multicenter, Randomized Clinical Trial Demonstrating Greater Efficacy…
The Journal of bone and joint surgery. American volume · 2020 · 57 citations

Nagy Mekhail
14 papers
Dawood Sayed
12 papers
Erika Petersen
12 papers
CY
Cong Yu
9 papers
Johnathan Goree
9 papers
KA
Kasra Amirdelfan
9 papers
Alaa Abd-Elsayed
8 papers
JS
James Scowcroft
8 papers
Shivanand Lad
8 papers · 4 as a resident
Timothy Deer
8 papers
Yashar Eshraghi
8 papers
NH
Nathan Harrison
7 papers

Clinical trials

a Diagnostic SIJ Injection Following a Composite of 3 Diagnostic Tests and a Pain Referral Diagram
Principal investigator · Completed
The Cleveland Clinic
2013–2016
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
Site PI · Recruiting
Brixton Biosciences, Inc.
2026–2029
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
Site PI · Recruiting · Phase 3
DiscGenics, Inc.
2025–2028
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
Site PI · Recruiting
VIVEX Biologics, Inc.
2025–2028